TEST BANK - Pharmacotherapeutics for Advanced Practice: A Practical Approach Fifth Edition( Virginia Poole Arcangelo, 2021)All chapters

FULLTEST
TEST BANK FOR PHARMACOTHERAPEUTICS FOR
n
n




n n
n




n




ADVANCED PRACTICE A PRACTICAL APPROACH 5TH n n n n n




EDITION BY VIRGINIA POOLE ARCANGELO; ANDREW
n n n n n n




PETERSON; VERONICA WILBUR; JENNIFER A. REINHOLD
n n n n n n




PRINTED PDF I ORIGINAL DIRECTLY FROM THE PUBLISHER I 1OO%
n n n n n n n n n




VERIFIED ANSWERS ] DOWNLOAD IMMEDIATELY AFTER THE ORDER
n n n n n n n n




['LIZ)LI12%5IL!


[LI.GIL


Complete Test bank, All Chapters are included.
n n n n n n




For more Test banks, ATI, HES! exams, and more contact us.
n n n n n n n n n n

, Tableofcontent n n




Chapter I Issues for the Practitioner in Drug Therapy
n n n n n n n n




Chapter 2 Pharmacokinetic Basis ofTherapeutics and Pharmacodynamic Principles
n n n n n n n n




Chapter 3 Impact of Drug Interactions and Adverse Events on Therapeutics Chapter
n n n n n n n n n n n n




4 Principles of Pharmacotherapy in Pediatrics, Pregnancy, and Lactation Chapter 5
n n n n n n n n n n n




Pharmacotherapy Principles in Older Adults
n n n n n




Chapter 6 Principles of Antimicrobial Therapy Chapter
n n n n n n




7 Pharmacogenomies
n n




Chapter 8 The Economics of Pharmacotherapeutics
n n n n n




Chapter 9 Pharmacotherapy of Pain Management
n n n n n n




Chapter I0 Pain Management in Opioid Use Disorder (OUD) Patients
n n n n n n n n n




Chapter 11 Cannabis and Pain Management
n n n n n n




Chapter 12 Contact Dermatitis
n n n




Chapter 13 Fungal, Viral, and Bacterial Infections ofthe Skin
n n n n n n n n n




Chapter 14 Psoriasis
n n n




Chapter I5 Acne Vulgaris and Rosacea Chapter
n n n n n n




16 Ophthalmic Disorders
n n n




Chapter I7 Otitis Media and Otitis Externa
n n n n n n




Chapter I8 Hypertension
n n n




Chapter I9 Hyperlipidemia
n n




Chapter 20 Chronic Stable Angina and Myocardial Infarction
n n n n n n n




Chapter 2I Heart Failure
n n n n




Chapter 22 Arrhythmias
n n




Chapter 23 Respiratory Infections
n n n




Chapter 24 Asthma and Chronic Obstructive Pulmonary Disease Chapter
n n n n n n n n




25 Gastric, Functional, and Inflammatory Bowel Disorders Chapter 26
n n n n n n n n n




Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapter 27
n n n n n n n n n




Liver Diseases
n n




Chapter 28 Urinary Tract Infection
n n n n




Chapter 29 Prostatic Disorders and Erectile Dysfunction Chapter
n n n n n n n




30 Overactive Bladder
n n n




Chapter 3I Sexually Transmitted Infections
n n n n




Chapter 32 Osteoarthritis and Gout
n n n n n




nChapter 33 Osteoporosisn n




Chapter 34 Rheumatoid Arthritis
n n n




Chapter 35 Headaches
n n n




Chapter 36 Seizure Disorders
n n n




Chapter 37 Alzheimer's Disease
n n n n




Chapter 38 Parkinson's Disease
n n n n




Chapter 39 Major Depressive Disorder and Bipolar Disorders
n n n n n n n




Chapter 40 Anxiety Disorders
n n n n




Chapter 41 Sleep Disorders
n n n




Chapter 42 Attention Deficit Hyperactivity Disorder
n n n n n




Chapter 43 Substance Use Disorders
n n n n n




Chapter 44 Diabetes Mellitus
n n n




Chapter 45 Thyroid and Parathyroid Disorders
n n n n n

,Chapter 46 Allergies and Allergic Reactions
n n n n n




Chapter 47 Human Immunodeficiency Virus
n n n n n




Chapter 48 Organ Transplantation
n n n n




Chapter 49 Thromboembolic Disorders
n n n




Chapter 50 Anemias
n n n




Chapter 5l Immunizations
n n




Chapter 52Smoking Cessation
n n n n




Chapter 53 Weight Loss Chapter
n n n n n




54 Contraception
n n




Chapter 55 Menopause
n n




Chapter 56 Vaginitis
n n

, lOMoAR n cPSD|
n21007614




lOMoAR n cPSD| n 21007614




Chapter 1 Issues for the Practitioner in Drug Therapy
n n n n n n n n




MULTIPLE CHOICE n




1. Nurse practitioner prescriptive authority is regulated by:
n n n n n n




A. The National Council of State Boards of Nursing
n n n n n n n




B. The U.S. Drug Enforcement Administration
n n n n




C. The State Board of Nursing for each state
n n n n n n n




D. The State Board of Pharmacy
n n n n




ANS: C n PTS: 1 n




2. Physician Assistant (PA) prescriptive authority is regulated by:
n n n n n n n




A. The National Council of State Boards of Nursing
n n n n n n n




B. The U.S. Drug Enforcement Administration
n n n n




C. The State Board of Nursing
n n n n




D. The State Board of Medical Examiners
n n n n n




ANS: D n PTS: 1 n




3. Clinical judgment in prescribing includes:
n n n n




A. Factoring in the cost to the patient of the medication prescribed
n n n n n n n n n n




B. Always prescribing the newest medication available for the disease process
n n n n n n n n n




C. Handing out drug samples to poor patients n n n n n n




D. Prescribing all generic medications to cut costs n n n n n n




ANS: A n PTS: 1 n




4. Criteria for choosing an effective drug for a disorder include:
n n n n n n n n n




A. Asking the patient what drug they think would work best for them
n n n n n n n n n n n




B. Consulting nationally recognized guidelines for disease management n n n n n n




C. Prescribing medications that are available as samples before writing a prescription
n n n n n n n n n n




D. Following U.S. Drug Enforcement Administration (DEA) guidelines for
n n n n n n n




n prescribing
ANS: B n PTS: 1 n




5. Nurse practitioner practice may thrive under health-care reform due to:
n n n n n n n n n




A. The demonstrated ability of nurse practitioners to control costs and improve patient
n n n n n n n n n n n




n outcomes
B. The fact that nurse practitioners will be able to practice independently
n n n n n n n n n n




C. The fact that nurse practitioners will have full reimbursement under health-care
n n n n n n n n n n




reform
n




D. The ability to shift accountability for Medicaid to the state level
n n n n n n n n n n




ANS: A n PTS: 1 n